Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Pharm Biomed Anal ; 118: 404-409, 2016 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-26609680

RESUMO

Cevimeline is muscarinic receptor agonist which increases secretion of exocrine glands. Cevimeline base is a liquid (m.p. 20-25 °C) at ambient conditions, therefore its pharmaceutical formulation as a solid hydrochloride hemihydrate has been developed. The synthesis of cevimeline yields its cis- and trans-isomers and only the cis-isomer is recognized as the API and used in the finished formulation. In this study structural and physicochemical investigations of hydrochloride hemihydrates of cis- and trans-cevimelines have been performed. Single crystal X-ray analyses of both cis- and trans-isomers of cevimeline are reported here for the first time. It was found that the cis-isomer, the API, has less dense crystal packing, lower melting point and higher solubility in comparison to the trans-isomer.


Assuntos
Contaminação de Medicamentos , Quinuclidinas/análise , Quinuclidinas/química , Tiofenos/análise , Tiofenos/química , Difração de Raios X/métodos , Cristalografia por Raios X/métodos , Agonistas Muscarínicos/análise , Agonistas Muscarínicos/química , Estereoisomerismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA